| 产品详情 |
| Edit |   |
|---|
| Product Name | ABBV-744 |
|---|
| Description | ABBV-744 is a BDII-selective BET bromodomain inhibitor that is being investigated to treat AML and metastic castration-resistant prostate cancer. |
|---|
| Size | 100 mg, 250 mg, 1 g |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | ABBV-744, ABBV 744, ABBV744, 2138861-99-9 |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | orb525750 |
|---|
| Price | |
|---|
| Order / More Info | ABBV-744 from BIORBYT LTD. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|